Open Government Portal
About this information
Open data is defined as structured data that is machine-readable, freely shared, used and built on without restrictions.
The key things to remember about open data are:
- #Availability and access#: the data must be available as a whole and at no more than a reasonable reproduction cost, preferably by downloading over the internet. The data must also be available in a convenient and modifiable form.
- #Re-use and redistribution#: the data must be provided under terms that permit re-use and redistribution including the intermixing with other datasets.
- #Universal participation#: everyone must be able to use, re-use and redistribute. There should be no discrimination against fields of endeavour or against persons or groups. For example, 'non-commercial' restrictions that would prevent 'commercial' use, or restrictions of use for certain purposes (e.g. only in education), are not allowed.
The legislation establishing Canada's Access to Medicines Regime contains a "Good Faith Clause" that provides patent holders with the right …
Within 30 days of the end of the two-year period of the original compulsory licence, a pharmaceutical company may apply …
Within 15 days of the day on which the compulsory licence was granted or the supply agreement was signed, whichever …
The pharmaceutical company must complete and submit to the Commissioner of Patents a Solemn or Statutory Declaration Under Paragraph 21.04(3)(c) …
The pharmaceutical company must complete and submit to the Commissioner of Patents one of the forms listed below. The company …
The company must submit the application package to the Commissioner of Patents at the Canadian Intellectual Property Office (CIPO).
A pharmaceutical company that holds a compulsory licence under Canada's Access to Medicines Regime is required to pay royalties to …
This process map provides a visual overview of the steps that need to be followed by a pharmaceutical company to …
This process map provides a visual overview of the steps that need to be followed by a pharmaceutical company that …
To participate in the Regime, a pharmaceutical company must enter into a sales agreement with an eligible importing country for …